Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
14 May 2013 -- Today the Technology Strategy Board (TSB) released its Delivery Plan for 2013-14, commenting on this announcement Steve Bates, BioIndustry Association (BIA) Chief Executive Officer, said:
"The Biomedical Catalyst scheme has been the most successful TSB programme for BIA members in the last year and I welcome the commitment of up to £30 million for a third round of the scheme in the 2013-14 Delivery Plan. The scheme is already leveraging additional private sector investment and helping companies expand more quickly delivering jobs and growth.
"The TSB's Delivery Plan for 2013-14 sets out a wide variety of programmes that can help innovative UK life science businesses grow more quickly. I encourage BIA members to take the opportunities provided by the initiatives that total more than £120 million in the health and high value manufacturing sectors this year.
"The BIA calls on the government to use the upcoming Spending Review to provide for additional funding to re-fill the Biomedical Catalyst to enable further rounds to meet demand. The Biomedical Catalyst has proven to be the government's most successful biotech initiative, is delivering jobs and growth and now needs to be secured for the future.
For further information, please contact Robert Winder, Head of Communications, email@example.com, 020 7630 2191; mobile 07825 942 934.
Technology Strategy Board Delivery Plan 2013-14
A breakdown of the most relevant actions in the delivery plan for UK bioscience is available on our website http://bit.ly/BIA_tsbdp
The Additional £50 million budget for the TSB highlighted by government today does not affect the TSB allocation to the BMC for 2013-14.
The third round of Biomedical Catalyst awards are expected to be announced in July.
BIA Biomedical Catalyst report
In March 2013 the BIA published a report on the Biomedical Catalyst. http://bit.ly/BIA_bmc
Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org
Help employers find you! Check out all the jobs and post your resume.